James Yarmolinsky

Imperial College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Collaborators (10)

Fotios Koskeridis

University of Ioannina

GREECE

View details

Abbas Dehghan

Reader in cardiometabolic diseases

Imperial College London

UNITED KINGDOM

View details

Emma Vincent

University of Bristol

UNITED KINGDOM

View details

Si Fang

Karolinska Institutet

SWEDEN

View details

Tom G. Richardson

UNITED KINGDOM

View details

Ko Willems van Dijk

Professor

Leiden University Medical Center

NETHERLANDS

View details

Claire Perks

University of Bristol

UNITED KINGDOM

View details

Virginia Díez-Obrero

Københavns Universitet

DENMARK

View details

Ioanna Tzoulaki

UNITED KINGDOM

View details

Tom Gaunt

Professor of Health and Biomedical Informatics

University of Bristol

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Yarmolinsky

Research Interests

Explore related searches

Contact this professor

Articles (9)

Genome-Wide Pleiotropy Analysis Identifies Shared and Opposing Pathways Influencing Coronary Artery Disease and Cancer

GLP-1 receptor agonists: an emerging tool for obesity-related cancer prevention?

The Effect of Circulating Proteins and Their Role in Mediating Adiposity’s Effect on Endometrial Cancer Risk: Mendelian Randomization and Colocalization Analyses

Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention

RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.

Association of germline TYK2 variation with lung cancer and non‐Hodgkin lymphoma risk

Mendelian randomisation analysis of circulating adipokines and C‐reactive protein on breast cancer risk

Collaborators (10)

Fotios Koskeridis

Abbas Dehghan

Emma Vincent

Si Fang

Tom G. Richardson

Ko Willems van Dijk

Claire Perks

Virginia Díez-Obrero

Ioanna Tzoulaki

Tom Gaunt

Make your next move.